ClinicalTrials.Veeva

Menu

Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 Patients (ACADEMY 1)

U

University of Campania "Luigi Vanvitelli"

Status

Unknown

Conditions

Myotonic Dystrophy 1
Sudden Cardiac Death

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of the study is to evaluate if the electrophysiological study (EPS) guided therapy, including the prophylactic implantation of implantable cardioverter defibrillator (ICD), in inducible patients, is able to improve survival in comparison with conventional therapy (CONV strategy) in Myotonic Dystrophy type 1 patients with conduction disorders.

Full description

Trial design:

This is a double-arm prospective observational study.

Patient population:

To be included in the study, DM1 patients had to have at least 18 years old, LVEF >35% on two-dimensional echocardiography, permanent pacing indication after non-invasive electrocardiographic evaluation or invasive EPS evaluation, according to the current guidelines. The following exclusion criteria were applied: electrolyte imbalance, thyroid disorders, prior cardiac surgery, prior cardiac arrest, prior spontaneous sustained ventricular arrhythmias, absuntion of antiarrhythmic drugs or medication known to affect cardiac conduction. All eligible DM1 patients underwent EPS for programmed ventricular stimulation; those in whom a sustained ventricula arrhythmia was inducible underwent subsequently ICD implantation. Non-inducible DM1 patients did not receive an ICD and underwent pacemaker implantation.

Endpoints:

The primary endpoint was all-cause mortality. Secondary end-points were sudden death (SD), death due to cardiac arrhythmias, ICD interventions and arrhythmic events in implanted patients.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • MD1 diagnosis genetically confirmed
  • LVEF >35% on two-dimensional echocardiography
  • Permanent pacing indication according to the current guidelines

Exclusion criteria

  • Electrolyte imbalance
  • Thyroid disorders
  • Prior cardiac surgery
  • Prior cardiac arrest
  • Prior spontaneous sustained ventricular arrhythmias

Trial design

70 participants in 2 patient groups

Positive EPS - ICD
Description:
Patients with inducible sustained ventricular tachycardia or ventricular fibrillation at EPS evaluation underwent ICD implantation
Negative EPS - PMK
Description:
All non inducible patients underwent PMK implantation

Trial contacts and locations

1

Loading...

Central trial contact

Vincenzo Russo, MD,PhD; Andrea Antonio Papa, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems